Article

AMD brings with it a higher risk of stroke and heart attack

Patients with age-related macular degeneration have twice the risk of dying from heart attack or stroke, according to Australian researchers.

Sydney, Australia-Patients with age-related macular degeneration (AMD) have twice the risk of dying from heart attack or stroke, according to Australian researchers.

"We found a positive long-term link between AMD and subsequent cardiovascular and stroke mortality in a population of older Australians," said lead researcher Paul Mitchell, MD, PhD, from the Centre for Vision Research in the Department of Ophthalmology at the University of Sydney. "This was particularly increased for late-blinding cases."

"Both ophthalmologists and general practitioners should be aware of this potential link and need to consider appropriate management of traditional vascular risk factors, such as smoking, blood pressure, blood lipids in their patients with AMD," Dr. Mitchell said.

When the study began people under 75 who had AMD were linked with doubling of their risk of dying from heart attack or stroke over the next 10 years. For people with late-stage AMD at the start of the study, the risk of dying from a heart attack increased five-fold, and the risk of dying from stroke increased 10 times, the team found.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.